Sai Parenteral's IPO — Date, Price Band, GMP & Allotment 2026
Sai Parenteral’s IPO is scheduled to open from 24 March to 27 March 2026, aiming to raise funds for expansion and working capital needs. Founded in 1998, the company operates in the pharmaceutical sector, focusing on manufacturing injectable medicines. Its business model centres on contract manufacturing and supplying hospitals and healthcare institutions. Sai Parenteral has a strong presence across India, particularly in western and northern regions, with growing distribution networks.
IPO Review
IPO GMP
IPO Subscription Subscription
Stock Price
As the IPO is listed, here is the Live Share Price for Sai Parenteral's
IPO Summary
What is the Sai Parenteral's IPO Timetable?
Track the IPO schedule and key events.
| Event | Date | Day |
|---|---|---|
| IPO Open Date | 24 Mar, 2026 | Tuesday |
| IPO Close Date | 27 Mar, 2026 | Friday |
| Basis of Allotment | 30 Mar, 2026 | Monday |
| Refunds Initiated | 01 Apr, 2026 | Wednesday |
| Credit to Demat | 01 Apr, 2026 | Wednesday |
| Listing Date | 02 Apr, 2026 | Thursday |
What is the Sai Parenteral's IPO Lot Size?
Bidding in multiples of 38 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 38 | ₹14,896 |
| Retail (Max) | 13 | 494 | ₹1,93,648 |
| S-HNI (Min) | 14 | 532 | ₹2,08,544 |
| S-HNI (Max) | 67 | 2546 | ₹9,98,032 |
| B-HNI (Min) | 68 | 2584 | ₹10,12,928 |
About Sai Parenteral's
The company’s product portfolio primarily includes injectable formulations such as antibiotics, analgesics, and other therapeutic drugs used in hospitals and healthcare institutions. It follows a business model that combines contract manufacturing and direct marketing, enabling it to serve both institutional buyers and third-party clients. Sai Parenteral emphasises quality control, modern manufacturing facilities, and adherence to regulatory standards, which supports its long-term growth. By maintaining strong relationships with clients and focusing on operational efficiency, the company aims to expand its footprint in the competitive pharmaceutical sector.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
Sai Parenteral's Key Performance Indicators (KPIs)
Objects of the Issue
| Issue Object | Estimate Amount |
|---|---|
| Capacity expansion and upgradation of manufacturing facilities | ₹110.80 Cr. |
| Establishment of a new R&D Centre; | ₹18.02 Cr. |
| Repayment / prepayment of certain outstanding borrowings | ₹14.30 Cr. |
| Working capital requirements | ₹33.00 Cr. |
| Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia); and | ₹33.00 Cr. |
| General corporate purposes |
Company Financials
The Sai Parenteral's company's financial performance (in ₹ Cr.) is summarized below:
| Metric | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 89.43 | 163.74 | 155.18 |
| EBITDA | 16.24 | 39.44 | 31.70 |
| Net Profit | 7.76 | 14.43 | 8.42 |
| Debt | 76.07 | 93.95 | 118.79 |
| Assets | 376.24 | 272.39 | 268.10 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Promoters and Shareholding Details
Promoter holding details will be updated as soon as they are officially announced.
Frequently Asked Questions
What is the GMP of Sai Parenteral's?
The current Grey Market Premium (GMP) of Sai Parenteral's is ₹ 00.
What is the Sai Parenteral's IPO Price Band?
The price band for Sai Parenteral's IPO is ₹372 to ₹392.
When is the Sai Parenteral's IPO Allotment?
The allotment date for Sai Parenteral's IPO is March 30, 2026.
How to check Sai Parenteral's IPO Allotment Status?
You can check the allotment status on the IPO Allotment Status page or on the registrar's website (Bigshare Services Pvt.Ltd.).
Official Documents
Company Contact Details
Registrar
Bigshare Services Pvt.Ltd.
Discussion 0
No comments yet
Be the first to share your thoughts!